NCT06619743Not yet recruiting
HPV Infection and Vaginal Microecology in Immunosuppressed Women
Study on HPV Infection and Vaginal Microecology in Immunosuppressed Women
Source: ClinicalTrials.gov · Last updated 1 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study intends to establish a screening cohort for HPV infection and related tumors in areas with high incidence of HIV infection, explore the screening of cervical cancer and anal cancer and the prognosis management model of precancerous lesions in HIV-infected women, and provide a scientific basis for the formulation of malignant tumor screening policies for this population in my country. In addition, this study intends to characterize the cervical, vaginal, and intestinal microecological characteristics of women with different HIV/HPV infection status, so as to explore the impact of cervical, vaginal, and intestinal microecological characteristics on persistent HPV infection or CIN/cancer progression.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 27 Sept 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Lan Zhu
- Diseases
- HIV, Cervical cancer
- NCT number
- NCT06619743
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Oct 2024 to the primary completion date, 31 Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Women who have had a previous cervical resection
- For subjects in vaginal microecology studies, women who used antibiotics within 2 weeks before collecting vaginal secretions, had sexual intercourse within 3 days, or used vaginal medication or vaginal douching within 48 hours need to be further excluded.
Other
- Unable to complete all screening processes independently
- Unable or unwilling to accept follow-up
Who the study is looking for
- HIV positive female, ≥18 years old
- HIV infection is sexually transmitted
- Have an intact cervix
- Have not received cervical cancer screening in the past 1 year
- No previous treatment for CIN/cervical cancer
- No clinical pregnancy symptoms
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.